- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 339
Gyroscope enters Orbit for merger
Gyroscope Therapeutics, spun out of Cambridge and Syncona, has merged with Orbit Biomedical to form a fully-integrated retinal gene therapy developer.
Apr 18, 2019Salary Finance rallies series C funding
Legal & General co-led the $32.8m series C round, which will fund the financial wellbeing platform's growth in the UK and US.
Apr 18, 2019SEB pitches stall at Fairpoint
SEB has formed a venture capital vehicle, Fairpoint Capital, to invest in B2B-focused startups out of a $97m fund with ex-SEB Venture Capital president Frederick Johansson as its head.
Apr 18, 2019Neurallys finds $850,000 alibi
IDF Innov-allied brain implant developer Neurallys plans to market sensors that measure intracranial pressure to combat the severe neurological complication hydrocephalus.
Apr 17, 2019Cytora slides into series B round
QBE and Starr Companies-backed insurance underwriting software provider Cytora has secured $32.6m in an EQT Ventures-led round.
Apr 17, 2019Cytora assesses $32.6m series B
Cambridge Innovation Capital and Parkwalk Advisors have both returned to back a $32.6m series B round for Cytora, an insurance technology spinout of Cambridge.
Apr 17, 2019Metry measures $1.5m investment
Chalmers Ventures has contributed to a $1.5m funding round for cleantech developer Metry.
Apr 17, 2019Vestas blows into Sowitec
The wind turbine maker has bought just over 25% of Sowitec, in the process securing a three-year option to wholly acquire the solar and wind project developer.
Apr 17, 2019Microlight3D binds to Smart Force Technologies
Microelectronics Technology Laboratory spinout Smart Force Technologies’ mask-less 2D microfabrication technology will be integrated with new 3D printers developed by Microlight3D.
Apr 16, 2019Boehringer Ingelheim regenerates Agomab
Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer spun out of University of Turin.
Apr 16, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


